Having demonstrated that loss of RSPO4 can push cells toward a more mesenchymal phenotype, we next performed sphere-formation assay to evaluate the effect of RSPO4 expression on tumor cell stemness, as EMT is known to correlate with stem-like properties in both normal and cancer cell lines. Here, RSPO4 is linked to neoplasm.